How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessment of tumor proliferation. The Swiss Working Group of Gyneco- and Breast Pathologists has surveyed inter- and intraobserver consistency of Ki-67-based proliferative fraction in breast carcinomas...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga, Zsuzsanna, Diebold, Joachim, Dommann-Scherrer, Corina, Frick, Harald, Kaup, Daniela, Noske, Aurelia, Obermann, Ellen, Ohlschlegel, Christian, Padberg, Barbara, Rakozy, Christiane, Sancho Oliver, Sara, Schobinger-Clement, Sylviane, Schreiber-Facklam, Heide, Singer, Gad, Tapia, Coya, Wagner, Urs, Mastropasqua, Mauro G., Viale, Giuseppe, Lehr, Hans-Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360682/
https://www.ncbi.nlm.nih.gov/pubmed/22662150
http://dx.doi.org/10.1371/journal.pone.0037379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360682/
https://www.ncbi.nlm.nih.gov/pubmed/22662150
http://dx.doi.org/10.1371/journal.pone.0037379

Ejemplares similares